Update on Celltrion Healthcare IPO
Celltrion Healthcare (CELLHZ KS) was initially expected to submit the IPO prospectus back in March. But it didn't do it because it was found to...
243 Views
The Disconnect Is Growing
Celltrion Inc (068270 KS) 's Inflectra, a biosimilar to Johnson & Johnson (JNJ US) 's Remicade, had little impact on the critical U.S. market...
603 Views
Celltrion Healthcare IPO - Summary on Last Week's IPO Roadshow in HK & Singapore
Celltrion Healthcare just completed the pre-IPO roadshows in Hong Kong and Singapore last week. The company officials met about 15 institutional...
344 Views
Revisiting Samsung BioLogics at This Interesting Time
I don't really intend to make any investment recommendation on BioLogics at this point. I have to admit that I'm still feeling the current price is...
243 Views
Recent Developments Not Encouraging
This Insight provides an update on developments in the US market related to biosimilars, and are of great significance to Celltrion Inc (068270...
153 Views